Tokioka T, Shimamoto Y, Suga K, Sueoka E, Matuzaki M, Ono K, Sano M, Nagumo F, Yamaguchi M
Department of Internal Medicine, Saga Medical School.
Rinsho Ketsueki. 1990 Jan;31(1):121-6.
Two patients with acute lymphocytic leukemia of B-cell phenotype (B-ALL) are described. They were 77-year-old female and 34-year-old male. One patient presented with marked splenomegaly, and the other with rupture of spleen on admission. Leukemic morphology revealed a typical L3 profile by FAB classification system in both cases. Immunologic analysis showed the presence of surface immunoglobulins in both cases, and one phenotype was IgM kappa, whereas the other was IgG kappa. Cytogenetic study revealed the typical translocations (8; 14) in both cases. Following chemotherapy, complete remission was achieved in one case, but the other died 36 days after admission. Including our two cases, we studied 12 cases of B-ALL and 77 cases of Burkitt's lymphoma reported in Japan, investigating the clinical prognosis as well as the biological features. We concluded that there are no significant difference of survival between B-ALL and Burkitt's lymphoma. We estimated it is due to oncogenesis from the same original cell in despite of the difference in main tumor site between two diseases.
本文描述了两名B细胞表型急性淋巴细胞白血病(B-ALL)患者。他们分别是77岁女性和34岁男性。一名患者入院时表现为明显的脾肿大,另一名患者入院时脾脏破裂。白血病形态学在两例中均通过FAB分类系统显示典型的L3型。免疫分析显示两例均存在表面免疫球蛋白,其中一例表型为IgM κ,另一例为IgG κ。细胞遗传学研究显示两例均有典型的(8;14)易位。化疗后,一例实现完全缓解,但另一例在入院36天后死亡。包括我们的两例在内,我们研究了日本报道的12例B-ALL和77例伯基特淋巴瘤病例,调查了临床预后和生物学特征。我们得出结论,B-ALL和伯基特淋巴瘤的生存率无显著差异。我们估计这是由于尽管两种疾病的主要肿瘤部位不同,但它们起源于相同的原始细胞。